title: Can exposure-based CBT extend the effects of intravenous ketamine in obsessive-compulsive disorder? an open-label trial.
authors.affiliation: Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California.|Veterans Affairs Palo Alto Health Care System, Palo Alto, California.
authors.forename: Carolyn I
authors.initials: CI
authors.lastname: Rodriguez
authors.forename: Michael
authors.initials: M
authors.lastname: Wheaton
authors.forename: Jordana
authors.initials: J
authors.lastname: Zwerling
authors.forename: Shari A
authors.initials: SA
authors.lastname: Steinman
authors.forename: Danae
authors.initials: D
authors.lastname: Sonnenfeld
authors.forename: Hanga
authors.initials: H
authors.lastname: Galfalvy
authors.forename: Helen Blair
authors.initials: HB
authors.lastname: Simpson
mesh_terms: D061605:Administration, Intravenous; D000293:Adolescent; D000328:Adult; D015928:Cognitive Behavioral Therapy / Q000379:methods*; D003131:Combined Modality Therapy; D006801:Humans; D007171:Implosive Therapy / Q000379:methods*; D007649:Ketamine / Q000008:administration & dosage* / Q000627:therapeutic use*; D008875:Middle Aged; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy* / Q000628:therapy*; D055815:Young Adult
chemical_list: D007649:Ketamine